Cipla

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE059A01026
  • NSEID: CIPLA
  • BSEID: 500087
INR
1,437.35
4.25 (0.3%)
BSENSE

Jun 24, 03:30 PM

BSE+NSE Vol: 22.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zydus Lifesci.
Lupin
Sun Pharma.Inds.
Mankind Pharma
Divi's Lab.
Biocon
Laurus Labs
Aurobindo Pharma
Dr Reddy's Labs
Torrent Pharma
Cipla

Why is Cipla Ltd. ?

1
Poor long term growth as Operating profit has grown by an annual rate 7.97% of over the last 5 years
2
With a fall in Net Sales of -7.54%, the company declared Very Negative results in Mar 26
  • The company has declared negative results for the last 2 consecutive quarters
  • PAT(9M) At Rs 2,790.00 cr has Grown at -31.87%
  • ROCE(HY) Lowest at 15.85%
  • NET SALES(Q) Lowest at Rs 6,541.20 cr
3
With ROE of 11.9, it has a Expensive valuation with a 3.4 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.38%, its profits have fallen by -22.5%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Cipla for you?

Low Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Cipla
-4.38%
-0.20
21.53%
Sensex
-6.17%
-0.47
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.01%
EBIT Growth (5y)
7.97%
EBIT to Interest (avg)
61.88
Debt to EBITDA (avg)
0.15
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.92
Tax Ratio
25.92%
Dividend Payout Ratio
27.07%
Pledged Shares
0
Institutional Holding
54.53%
ROCE (avg)
21.59%
ROE (avg)
14.00%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
28
Industry P/E
35
Price to Book Value
3.37
EV to EBIT
23.06
EV to EBITDA
18.31
EV to Capital Employed
4.13
EV to Sales
3.83
PEG Ratio
NA
Dividend Yield
0.90%
ROCE (Latest)
17.93%
ROE (Latest)
11.87%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NO KEY POSITIVE TRIGGERS
-22What is not working for the Company
PAT(9M)

At Rs 2,790.00 cr has Grown at -31.87%

ROCE(HY)

Lowest at 15.85%

NET SALES(Q)

Lowest at Rs 6,541.20 cr

PBDIT(Q)

Lowest at Rs 954.95 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 14.60%

PBT LESS OI(Q)

Lowest at Rs 558.90 cr.

EPS(Q)

Lowest at Rs 6.87

Loading Valuation Snapshot...

Here's what is not working for Cipla

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 558.90 cr has Fallen at -57.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 1,318.37 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 554.64 cr has Fallen at -53.3% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 1,188.71 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 6,541.20 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 6,541.20 cr has Fallen at -7.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 7,087.77 Cr
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 954.95 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 14.60%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 558.90 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 6.87
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)